A single dose of MSC-CM applied to SGC-7901 tumor cells resulted in tumor cell expression of VEGF and RhoA-GTPase and ERK1/2 activation leading to enhanced tumor growth that was maintained through serial transplantation experiments[224]. Here, RHOA is linked to neoplasm.